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Highlights: 
 Hair samples present considerable opportunities for assessing cortisol in cohorts. 
 Certain hair characteristics correlate with hair cortisol concentrations (HCC). 
 Mental and physical health status is independently associated with HCC. 
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Abstract 
Hair cortisol concentrations (HCC) have been suggested to reflect long-term integrated cortisol levels, 
but most evidence of associations with co-variates is from small samples of healthy volunteers. 
The objective of this study was to describe the collection of hair samples in a large cohort study and 
report associations of demographic and health measures with HCC. We examined HCC measured 
from the 3 cm hair segment near the scalp in 3,507 participants (aged 59-83y) from The Whitehall II 
occupational cohort study of British civil servants. Hair samples were analysed using a column 
switching LC–APCI–MS/MS assay. Findings from mutually adjusted linear regression analyses 
revealed lower HCC in participants who reported use of hair dye [% difference (95%CI); -13.6 (-
22.9,-3.1), p value=0.01] and evidence suggestive of differences by length of sample storage and 
seasonal variation. With regard to demographic variables, HCC was lower in women compared to 
men [-17.7 (-25.4 -9.2), p value <0.001] and higher in Black compared to other ethnic groups. 
Prevalent diabetes, use of systemic corticosteroids and cardiovascular medication were independently 
associated with higher HCC. With regard to health, depressive symptoms were associated with higher 
HCC [19.3 (7.4, 32.6), p value =0.001] following adjustment for physical disease and medication. We 
conclude that hair steroid analysis presents significant opportunities for assessing cortisol in large 
scale cohorts. Demographic factors, sample storage, season of collection and hair characteristics 
should be considered in future analyses. Health status, both mental and physical, is linked to HCC. 
 
Key words: cortisol; depressive symptoms; diabetes; medications 
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1. Introduction  
 
Understanding the role of stress in health continues to be a major aim in epidemiological research. 
Activation of the hypothalamic-pituitary-adrenal (HPA) axis is a primary response to a stressful 
stimulus and cortisol, the end product of the HPA axis, which may mark exposure to chronic stress, is 
proposed as a mediator between adverse social conditions and physical health.  
 
Observational surveys frequently collect cortisol from their participants to allow these pathways 
between stress and health to be examined. Traditionally, the assessment of cortisol in observational 
surveys has been through measurements in blood, saliva or urine. However, high state reactivity and 
the pulsatile secretion of cortisol (Hellhammer et al., 2007; Lightman et al., 2008; Young et al., 2004) 
mean single measurements reflect short-term levels, ranging from minutes (plasma or saliva) to hours 
(urine), and provide limited information about long-term cortisol secretion. Repeated ambulatory 
measurements which capture longer-term levels, require high levels of commitment from participants, 
are time-consuming, expensive and may include high proportions of missing data due to participant 
non-compliance (Broderick et al., 2004). In addition, these methods are often invasive and require a 
clinic environment to aid collection or they require high levels of commitment from the participants, 
which becomes harder to request in certain groups e.g. studies of ageing. Thus, blood, saliva and urine 
measures, while well-suited for capturing dynamic aspects of endocrine activity, (e.g., acute stress 
reactivity or diurnal rhythmicity), are less useful as markers of the long-term secretory patterns. 
However, long-term cortisol levels may be important in the aetiology of chronic disease, since the 
cumulative burden of frequent or enduring HPA axis activation may be associated with a range of 
maladaptive effects on the organism. 
 
Hair cortisol concentration (HCC) can provide an alternative assessment method, capturing 
information about cortisol levels over the course of several months. The collection of hair samples is 
non-invasive and can be performed by non-health care workers at any time of the day. Hair samples 
can also be stored at room temperature and be sent by mail. Although forensic science and toxicology 
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have an established history of analysing hair for exogenous substances, recent reports that endogenous 
steroids can also be detected in hair have expanded research using human hair samples(Meyer and 
Novak, 2012; Russell et al., 2012; Stalder and Kirschbaum, 2012). Direct and in-direct validation 
studies have confirmed the capacity of these measures to provide an index of integrated long-term 
cortisol secretion (Meyer and Novak, 2012; Russell et al., 2012; Stalder and Kirschbaum, 2012) 
despite lack of understanding of the precise means by which cortisol is incorporated into the hair shaft 
(Sharpley et al., 2012). High intra-individual stability in HCC supports the use of this method in 
epidemiological research to assess long- term cortisol secretion (Stalder et al., 2012b).   
 
Several issues potentially affect HCC measurements. First, small scale studies have documented 
differences in HCC by a range of characteristics such as sex, age and ethnicity implying that without 
controlling for these and other confounding factors, biased results could be obtained (Russell et al., 
2012; Sharpley et al., 2012; Staufenbiel et al., 2015; Wosu et al., 2013). Second, differences in HCC 
by physical and mental health have been observed, with elevated HCC in patients with chronic 
conditions such as diabetes (Feller et al., 2014; Henley et al., 2013; Manenschijn et al., 2013) and 
myocardial infarction (Pereg et al., 2011) as well as mental health problems (Staufenbiel et al., 2013). 
These findings suggest that when measuring HCC it may be important to take into account health 
status, although these studies were often composed of small samples of patients or based on self-
reported diagnoses and therefore the exact effect on HCC remains unclear. Third, human hair is 
exposed to exogenous factors, including hair maintenance products, such as hair dye, shampoo and 
chemical treatments. Identifying whether these factors are potential sources of measurement error is 
crucial (Dettenborn et al., 2012b; Feller et al., 2014; Wosu et al., 2015). Although certain 
characteristics, such as dyeing and other chemical treatment of hair have been found to be associated 
with reduced HCC (Manenschijn et al., 2011; Stalder et al., 2013), samples have not always been 
large enough to examine the full range of hair maintenance procedures.  
 
To date, HCC has been assessed in some larger samples up to N=1,258 (Braig et al., 2015; Feller et 
al., 2014; Stalder et al., 2013; Staufenbiel et al., 2015) but the majority of them may lack 
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representiveness, being drawn from volunteers. To address limitations of sample size and 
generalisability we assessed HCC in a large well-characterised longitudinal cohort study to examine 
the feasibility of this measure for future observational research. Our objectives were to describe the 
procedure of collecting and validating hair samples for HCC analysis and to examine the association 
between HCC and a range of factors. We examined these data in relation to hair characteristics, 
demographical characteristics, and health status. We also explored the influence of sample storage and 
seasonal effects, the impact of which are not well known. Furthermore, we wished to examine the 
association between clinically screened physical health events and mental health status with HCC.  
 
2. Methods 
 
2.1 Study population  
 
The Whitehall II study is an occupational cohort originally recruited from London based Civil Service 
departments in 1985-1988 (phase 1). The initial sample consisted of 10,308 participants who 
undertook a clinic screening and completed a postal questionnaire. Follow up screening examinations 
were conducted in 1991-1993 (phase 3) and 1997-1999 (phase 5), 2003-2004 (phase 7), 2007-2009 
(phase 9) and 2012-2013 (phase 11). Postal questionnaires were sent to participants in 1989 (phase 2), 
1995 (phase 4), 2001 (phase 6) and 2006 (phase 8). Hair cortisol data were collected for the first time 
in 2012-2013 (phase 11). Further details of the Whitehall II Study can be found elsewhere (Marmot 
and Brunner, 2005). Ethical approval for the Whitehall II study was obtained from the University 
College London Medical School committee on the ethics of human research. 
 
2.2 Hair sample collection  
 
A total of 6,308 participants were included in phase 11, of whom 5,660 undertook a clinical 
screening. A sample of hair was taken from 4,460 participants, excluding those who had insufficient 
hair (N=997), who had a severe head tremor (N=31) or who didn’t consent (N=172). Women were 
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more likely to provide a sample than men (78.6% vs. 67.4%).  Hair strands taken from the head by a 
nurse were cut carefully with scissors as close as possible to the scalp. Hair was collected from the 
vertex posterior region of the head, since it has been found that this area of the scalp has the greatest 
growth cycle synchrony and exhibits the lowest intra-individual variability in HCC (Sauve et al., 
2007). Steroid concentrations were determined from the 3cm segment of hair closest to the scalp. This 
represents hair growth over the three month period prior to sampling based on an average hair growth 
of 1cm/month (Wennig, 2000).   
 
2.3 Sample preparation 
 
The samples were analysed between 23rd June  and 20th August in 2014 using a column switching 
LC–APCI–MS/MS assay, which has been found to be a sensitive, reliable method for quantifying 
steroids in human hair (Gao et al., 2013). The samples were washed and steroids extracted following 
the protocol described previously (Gao et al., 2013; Stalder et al., 2012b) with minor changes to allow 
analysis by liquid chromatography-tandem mass spectrometry (LC-MS/MS).  The intra and inter-
assay coefficients of variation (CVs) for cortisol analysis by this method have been reported to range 
between 3.7% and 8.8%.  11 samples were not analysed due to insufficient sample or technical error.  
A total of 4,449 samples were analysed for HCC but samples that weighed less than 7.5mg (N=404) 
were excluded from the analyses for this study as were those with samples shorter than 3cm (N=61). 
Following sensitivity analysis, samples shorter than 3cm (N=193) but with sufficient weight were 
included, since shorter length alone was not associated with differences in HCC. Samples in which the 
scalp end of the hair was not obvious were also excluded (N=7). This left a total of 3,977 respondents, 
of whom 3,966 had also completed the accompanying hair questionnaire.  
 
2.4 Assessment of covariates  
 
Information about hair-related characteristics was collected via a questionnaire (Appendix 1) 
administered when the hair sample was collected. Participants were asked whether they dyed or 
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treated (perm or chemical treatment) their hair. They were also asked about the number of times per 
week they washed their hair with shampoo. This was recoded as: once a week or less, 2-4 times per 
week and daily or 5-6 times per week. Interviewers’ assessed the colour of the hair sample taken, 
although participants were also asked about their natural hair colour, if they had used hair dye. Seven 
categories of hair colour were specified on the questionnaire (1: grey/white, 2: blond, 3: red, 4: brown, 
5: black, 6: don’t know, 7: other). These were recoded into five categories: 1) grey/white, 2) blonde 3) 
red, 4) brown, 5) black. If ‘don’t know’ was specified then this was recoded into missing. If ‘other’ 
was chosen and another hair colour was specified in the open question provided, these were recoded. 
Information on age, sex, last-known civil service employment grade and ethnicity was obtained from 
the general questionnaire at phase 11. Civil service employment grade was defined using three tiers: 
1) administrative, 2) professional or executive and 3) clerical or support. Ethnicity was self-defined as 
White, South Asian, Black or Other. Participants provided details of current medications use (generic 
name, brand name, or both); these were subsequently coded using the British National Formulary. 
This study used information about participants who used steroid medication (local and systemic) and 
cardiovascular medication in the last 14 days. Date of hair collection was used to calculate variables 
related to length of sample storage and season of collection:  winter (Dec, Jan, Feb), spring (Mar, Apr, 
May), summer (Jun, Jul, Aug) and autumn (Sep, Oct, Nov). An eight category variable was created to 
take account of hair growth which during the three month sample overlapped two seasons: (1: winter, 
2: winter-spring, 3: spring, 4: spring-summer, 5: summer, 6: summer-autumn, 7: autumn, 8: autumn-
winter). Mental health status was assessed using The Center for Epidemiologic Studies – Depression 
scale (CES–D), a 20 item scale that measures symptoms of depression in the general public, a score of 
16+ has previously been used to classify depression (Radloff, 1977). Height and weight were 
measured using standardised protocols during the medical examination and BMI (kg/m2) was 
calculated. Participants were asked about doctor diagnosis of diabetes at each phase. Diabetes 
medication was extracted, again using British National Formulary codes (BNF).  Venous blood was 
taken at study phases 3, 5, 7, 9 and 11 to assess biomarkers, such as fasting glucose and HbA1c 
(plasma cortisol was not measured). Prevalent diabetes at phase 11 was defined either by fasting 
glucose (fasting≥7) (WHO, 2006) or HbA1c (≥6.5%) (WHO, 2011)  or self-reported diabetes; doctor 
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diagnosis, use of insulin or oral glucose lowering drugs. Prevalent CHD was assessed from medical 
records 1985-2009, supplemented by reports of doctor diagnosis at phase 11 and self-reports of a 
heart attack, angina pectoris or other heart trouble since 2008. Stroke, likewise was assessed using 
medical records up to phase 9 or doctor diagnosis/self-report of a stroke since 2008.  
 
2.5 Statistical analysis 
 
HCC values were positively skewed and therefore log transformed to establish a normal distribution. 
Eighty-five outliers ±3SD from the mean were excluded from the analyses. The association between 
each exposure variable (independent variable) and HCC was assessed initially using linear regression 
and subsequently using multiple regression with adjustment for potential confounding variables. 
Regression analyses were first conducted on demographics and hair related variables, followed by 
medication and health status. Percentage differences in mean HCC between the levels of each 
exposure variable were calculated from the regression coefficients for each exposure variable using 
the formula: Percentage difference = (exp(coefficient) – 1.0)*100  
 
3. Results  
Table 1 provides characteristics of the 3,6975 participants included in the final sample.  This analysis 
was based on 3,675 participants who provided a hair sample of sufficient weight and an identifiable 
scalp end, completed a hair questionnaire and did not have missing data on the covariates of interest. 
Mean age of participants at phase 11 was 70 years.  The majority of participants were men (68.4%), 
reported their ethnicity as white (94.2%) and had a last known civil service employment grade of 
executive or above. Sample collection was distributed evenly across the year and most had been 
stored for more than 18 months before analysis because samples were assayed in a single run at the 
end of data collection. Seven percent of participants (N=264) were taking local corticosteroids and 2% 
(N=70) systemic corticosteroids. The majority of the participants from whom samples were collected 
were free of chronic health conditions and had a BMI between 18.5 and 29.9.  Table 2 shows the 
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characteristics of those included and not included in this analysis. Overall the samples were similar 
across a range of variables, although differences by sex and mean HCC were observed.   
 
Table 3 shows that women had lower HCC than men both before and after adjustment for potential 
confounders. There was no significant difference in HCC by age group or when age was used as a 
continuous variable (percentage difference per year of age =0.1%, p=0.73). There was no initial 
difference in HCC by ethnic group, however in mutually adjusted analysis those who identified as 
Black had nearly 40% higher HCC than White groups.  In the initial simple linear regression analysis, 
HCC was lower in the lower employment grades (prof/exec clerical/support) than in the higher 
(administrative) employment grade, but this association attenuated following adjustment.  
 
Those who reported having dyed hair had lower HCC than those who did not.  Although those who 
reported chemically treated hair had higher HCC initially, most of this difference was removed after 
adjustment for demographic and other hair characteristics.  There was no significant difference in 
HCC by frequency of hair washing in the linear model. However, after controlling for other hair 
characteristics those who washed their hair more than 4 times a week had lower HCC than those who 
only washed it once a week or less, although this was not statistically significant (p=0.08). Although 
there were no differences in HCC by hair colour in the unadjusted analyses, the mutually adjusted 
analysis showed that those with black hair had slightly higher HCC on average, compared to those 
who had grey or white hair. 
 
Hair samples with hair growth from winter-spring, spring, spring-summer, summer and summer-
autumn had higher HCC compared to those collected in winter, but these differences remained for the 
winter-spring, spring, spring-summer and summer, seasons only in the adjusted analyses. HCC was 
lower in hair samples stored for over 18 months, compared to those stored for <18 months.  A 
negative association (r= -0.02, p=0.001) between months of storage and HCC was also observed when 
months of storage was included as a continuous variable in unadjusted linear analysis. The large 
difference observed between unadjusted and adjusted analyses for months of storage is perhaps due to 
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the correlation between storage and season e.g. no sample collected in Spring in the study was stored 
for <18 months.  
 
Table 4 presents the association of HCC with medication intake and health status. Participants who 
took systemic corticosteroids had lower HCC compared to those who did not and this association 
remained following adjustment for demographic factors, hair characteristics and health status. Those 
who were currently taking CVD medication compared to those who were not, had higher HCC 
initially, although this association was no longer significant in adjusted analysis. There was a 
significant association between BMI and HCC, participants who had a BMI higher than 25 kg/m2 
(healthy weight) had higher HCC. Participants with diabetes exhibited higher HCC than those who 
did not and this remained significant in the fully adjusted analysis. HCC was unrelated to CHD 
diagnosis or the experience of a stroke. A positive association between HCC and depressive 
symptoms was observed in the simple linear regression which remained when other factors were 
taken into account (figure 1). 
 
 
4. Discussion  
 
This study is the first to test the feasibility of using of hair cortisol as a measure of long-term cortisol 
exposure in a large scale occupational cohort study. Sample collection was well tolerated, quick and 
relatively cheap. The study was well-powered to detect correlates of HCC and our results show 
associations of HCC with hair treatment, hair washing, and season of sample collection and health 
conditions.  
 
We considered a group of hair specific factors, collected in the accompanying questionnaire and 
which have been considered previously. Our results suggest those participants who had black hair 
having slightly higher HCC than those with grey/white hair. This contrasts with previous research 
which suggests no influence of natural hair colour on HCC in human hair samples (Dettenborn et al., 
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2012a; Dettenborn et al., 2012b; Kirschbaum et al., 2009; Manenschijn et al., 2011; Raul et al., 2004; 
Sauve et al., 2007).  The majority of previous studies have not distinguished between hair treatment 
and hair dye. Those studies which did, found participants who had dyed their hair had lower HCC, in 
accord with our results (Manenschijn et al., 2011; Sauve et al., 2007). Studies which did not 
differentiate between chemical treatment and hair dye also found lower HCC in participants who 
reported treating their hair (Manenschijn et al., 2012; Stalder et al., 2013). In our study, we found that 
hair treatments, such as perming or straightening, did not have an independent association with HCC 
after adjusting for the presence of hair dye.  We see a consistent association between hair dye and 
HCC and therefore recommend that information about whether participants use hair dye is always 
collected and included in HCC analysis. 
 
We found that participants who washed their hair every day had lower HCC than those once a week 
or less, although this effect was relatively small. This finding stands in contrast to most previous 
studies which have found no significant relationship between HCC and regular hair washing with 
shampoo (Groeneveld et al., 2013; Kirschbaum et al., 2009; Manenschijn et al., 2011; Stalder et al., 
2013; Stalder et al., 2010). An experimental study found HCC decreased after washing with shampoo 
(Li et al., 2012), although this was only based on a sample size of three and hair samples being  
immersed in a shampoo solution. Dettenborn and colleagues (2012) found a negative association 
between hair washing frequency and HCC, but only in the hair segment most distal from the scalp 
(Dettenborn et al., 2012a). Although an association between frequency of hair washing and HCC is 
suggested, this does not remain in mutually adjusted analysis. We recommend that studies collect 
information about the frequency of hair washing and additional research explores this issue further. 
 
Seasonal variation has been examined previously, with higher HCC reported in the summer months 
and lower HCC in winter (Braig et al., 2015; Staufenbiel et al., 2015).  The present results based on a 
large sample and even sample collection across the four seasons suggested seasonal differences in 
HCC in the opposite direction, i.e. we found lower HCC in samples collected in winter-spring, spring, 
spring-summer and summer seasons compared to those collected in the winter.  This could suggest 
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seasonal differences in environmental influences on hair samples or seasonal variation in long-term 
cortisol secretion. Several hypotheses for the influence of season on HCC have been proposed, 
including temperature, fluid ingestion and transpiration (Braig et al., 2015). Seasonal variation in 
mood could also be a confounding factor, although, in our sample the association between HCC and 
season was unaffected when adjustment was made for depressive symptoms. A possible interaction 
between season of sample collection and length of storage has also been suggested (Braig et al., 2015) 
although few studies have examined the influence of length of storage on HCC. We found a storage 
effect with HCC lower in samples that had been stored for longer. Importantly, our results suggest 
that the respective influences of the season of hair collection and of sample storage are independent of 
each other, i.e. they emerged after mutual accounting for each other.  There are a number of reasons 
which might explain why previous findings on the seasonal variation in cortisol levels are 
inconsistent. Firstly the previous studies have used samples drawn from different populations from 
different European countries: Braig and colleagues  (2015) examined the association between season 
and HCC in a sample of mothers who had recently given birth in Germany, whilst Staufenbiel and 
colleagues examined HCC in healthy, middle-aged women and men in the Netherlands (2015). 
Although these are both European countries it is possible that temperature and humidity levels, may 
differ between these countries and the UK. Furthermore, it is not possible to completely rule out an 
interaction between season and storage in earlier studies. Since in large scale observational studies it 
will not always be possible to control which season sample collection occurs in or the length of 
sample storage, it is advisable to collect sufficient information to allow these environmental features 
to be taken into account. 
 
Sex remained a significant predictor of HCC in the present study after adjustment for a range of other 
characteristics, with women having lower HCC than men. Overall results from previous work on sex 
differences in HCC have been mixed. A recent study found that sex differences were not independent 
of other covariates (Feller et al., 2014) and others have found no differences (Gao et al., 2010; 
Manenschijn et al., 2011; Raul et al., 2004; Stalder et al., 2013; Thomson et al., 2010). However,  
Dettenborrn and colleagues (2012) also found elevated HCC in men (Dettenborn et al., 2012b). This 
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accords with the present findings and also two previous studies, which demonstrate higher HCC in 
males compared to females (Manenschijn et al., 2013; Staufenbiel et al., 2015). A possible mechanism 
for higher HCC in men compared to women is the higher 24-h urinary glucocorticoid secretion rate in 
men (Remer et al., 2008).  
 
 In common with the majority of previous studies (Kirschbaum et al., 2009; Manenschijn et al., 2011; 
Manenschijn et al., 2012; Raul et al., 2004; Stalder et al., 2012a), we found no association between 
HCC and age in our sample of participants aged 59-84. However, research that has examined 
individuals across wider age ranges reported positive associations between age and HCC (Dettenborn 
et al., 2012b; Feller et al., 2014; Stalder et al., 2013); with HCC increased for adults between 50-91 
years. Although these differences may be due to the different samples under observation, this may 
also suggest that such age-related changes in HCC occur in early old age. A recent study which 
specifically examined HCC in adults between 47-82 years found age-related changes in HCC, which 
were consistent even after controlling for other factors (Feller et al., 2014). However, strong positive 
correlations have also been observed between age and HCC in studies with narrower age ranges 
(Manenschijn et al., 2013; Staufenbiel et al., 2015). 
 
Several hypotheses have been offered to explain a difference in HCC by ethnicity (Wosu et al., 2015; 
Wosu et al., 2013). Firstly, that certain ethnic groups are more likely to be exposed to social stressors, 
secondly that there are differences in the hair texture and growth rate in different ethnic groups and 
thirdly that hair maintenance practices may differ amongst ethnic groups.  Our findings suggest higher 
HCC in Black groups compared to other ethnic groups. Studies from the US have reported no 
differences by ethnicity and higher HCC in Black groups  (Wosu et al., 2015) (O'Brien et al., 2013), 
however both have suggested that their findings might be confounded by socioeconomic position. We 
found that this association was independent of last known employment grade, suggesting that 
socioeconomic position might not fully explain these disparities. We also found these differences by 
ethnicity to be independent of washing frequency, use of hair dye and chemical treatment which 
suggests that hair maintenance practices may not account for these differences either. However, these 
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findings require further analyses because of the small number of cases of each different ethnic group 
in our population. 
 
In our study an initial difference in HCC by last known employment grade was found. However, this 
association was not independent of sex. Several articles have examined the association between 
educational level and HCC in adults (Boesch et al., 2015; Serwinski et al., 2016)  and children (Rippe 
et al., 2016). Chen and colleagues (2013) found no association between educational level and HCC in 
adults in China. At the current screening many participants were retired, therefore these analyses need 
further exploration with non-occupational measures of social position.    
 
To the best of our knowledge, the association of medication intake with hair cortisol levels has not 
been examined, although a study which examined general medication intake found no difference in 
HCC (Kirschbaum et al., 2009). Due to the size and structure of our cohort we were able to examine 
the association between HCC and several groups of medication. We found that those who took 
systemic corticosteroids had lower HCC compared to those who took no steroid medication. 
However, in a sample which retained outliers, both local and systemic were associated with higher 
mean HCC than those who did not (data not shown). We anticipate that certain outliers for the topical 
corticosteroids might be explained by participants using creams/gels that came into direct contact with 
the scalp/hair. Synthetic GCs (Dexamethasone, Betamethasone, etc.) should not produce a cortisol-
like signal in the MS  (i.e. cross-react), only the use of actual hydrocortisone medication would do 
this. In further analysis (Supplementary Table S1) we show that participants with lower hair cortisol 
were using glucocorticoid therapy and those with higher hair cortisol were using topical 
corticosteroids. This suggests that perhaps some of the extreme HCC results observed can be 
attributed to medication use, research which has examined HCC thus far tends to exclude participants 
taking corticosteroid medication from the study and this seems to be a sensible strategy.  We also 
found evidence of an association between BMI and HCC, with participants with a BMI 25 kg/m2 or 
higher (overweight or obese) having higher mean HCC than their normal weight counterparts. This 
finding accords with previous research which finds an association of obesity with greater cortisol 
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excretion in urine, which also reflects overall output  (Brunner et al., 2002) and tstudies that examine 
HCC and obesity in children (Veldhorst et al., 2014) and adults (Feller et al., 2014; Stalder et al., 
2013; Stalder et al., 2012a). Cortisol might be directly related to adiposity in humans through 
adipocytes. Visceral adipose tissue expresses high concentrations of glucocorticoid receptors  (Pou et 
al., 2007) and it is thought that adipocytes are a source of cortisol. In humans increased 11β-HSD1 
activity, which regulates glucocorticoid metabolism at the tissue level, has also been associated with 
features of the metabolic syndrome (Walker and Andrew, 2006)  
 
We also examined the association of HCC with three chronic conditions; diabetes, CHD and stroke. 
The present results revealed increased HCC in people with type 2 diabetes after full adjustment for 
potential confounding influences. This concurs with previous data of elevated HCC in patients with  
diabetes (Feller et al., 2014; Henley et al., 2013; Manenschijn et al., 2013) and is also in line with 
findings that HCC is positively related to glycated haemoglobin (a marker of long-term plasma 
glucose concentrations) and prevalence of the metabolic syndrome (Stalder et al., 2013). Despite 
previous research suggesting an independent relationship between HCC and cardiovascular disease 
(Manenschijn et al., 2013) and elevated HCC in patients with acute myocardial infarction (Pereg et 
al., 2011) we found no evidence of this in our cohort. Although we find an association between taking 
CVD medication and HCC, this does not remain when other factors, such as BMI, were taken into 
account. Certain CVD medications, e.g. statins, are prescribed in high-risk disease-free groups for 
primary prevention in addition to being prescribed as therapy for CHD patients. Certain CVD risk 
factors are considered by family doctors (GPs) in the UK as predictive of developing CVD at some 
point in the next ten years. HCC may be associated with these risk factors and predictive of being 
prescribed CVD medication rather than being actual markers of CHD or stroke. We have provided 
further information (Table S2) in the Appendix to demonstrate this. Furthermore, it is possible that 
statin use is causing weight gain (Swerdlow et al., 2015) which is then associated with HCC (p.14) 
 
We found an independent association between depressive symptoms, measured using the CES-D scale 
and HCC, such that those who reported more depressive symptoms had increased HCC.  This accords 
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with previous findings (Dettenborn et al., 2012a; Stalder et al., 2014), although most work in this area 
has been on small samples recruited because of their diagnosis or an existing physical health condition 
(Staufenbiel et al., 2013). Therefore, we believe this to be the first report of an independent 
association between depressive symptoms and HCC in a large observational cohort.  
 
There are certain limitations that must be acknowledged. At this phase (11) of the study only hair 
cortisol data were available, thus the HCC results presented here could not be compared to those from 
other types of body fluids.  Since this field of research is in its infancy, a clear distribution of potential 
values has not been established, although this is perhaps comparable to other existing methods of 
cortisol assessment, e.g. in saliva or urine. Due to the age and demographic distribution of this cohort, 
a number of participants were not able to provide a hair sample of sufficient length for analysis. 
Although we attempted to minimise within individual variation in hair growth by taking hair from the 
vertex posterior region of the head, hair growth rates may vary between individuals. Furthermore the 
participants in this cohort at this phase have a mean age of 70 years older, therefore it may not 
possible to generalise the findings of this study to younger adults.  In the Whitehall II cohort there are 
few participants who report that they are from an ethnic group other than white, therefore our findings 
on the association between ethnicity and HCC is not generalizable to a wider population and 
additional research will be required to explore this finding further. There are, however, strengths to 
this study, primarily that hair samples have been drawn from a large sample, from which a range of 
other variables have also been assessed. In addition, the quantification of HCC by LC-MS/MS, which 
is considered the current gold-standard approach for such analyses, comprises a clear strength of this 
paper.  
 
Collecting hair samples in occupational cohorts present significant opportunities for assessing cortisol 
and other steroids; especially since the collection is cheaper and less invasive than previous methods 
of measuring cortisol. We conclude that several demographic factors, hair characteristics and details 
of hair care routines are correlated with hair cortisol and are important to collect when wishing to 
analyse cortisol in hair. We recommend that information on medication and seasonal variation should 
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be collected and considered as possible confounders in analyses. We also recommend that further 
research assesses the impact of storage length on hair samples and that information regarding storage 
length be recorded and taken into account in the analysis.  Similarly, mental and physical health is 
associated with HCC levels and should be taken into in the analysis. We therefore recommend 
collecting hair samples for assessing HCC if long-term levels of cortisol are of interest and a high 
response rate is unlikely using traditional repeated urine or saliva measures. 
 
Disclosure Statement: The authors have nothing to disclose. 
 
Author contributions: JA and MKu designed the study and wrote the first draft of the manuscript. 
TS and CK conducted the sample analyses.  JA analysed the data.  All authors (JA, TS, JF, MJS, CK, 
MKi & MKu) interpreted the results and assisted with the preparation of the manuscript. 
 
ROLE OF FUNDING SOURCE 
 
The Whitehall II study has been supported by grants from the Medical Research Council (K013351); 
British Heart Foundation; National Heart Lung and Blood Institute (R01HL36310), US, NIH: 
National Institute on Aging (R01AG13196 and R01AG34454), US, NIH; Agency for Health Care 
Policy Research (HS06516); and the Dunhill Medical Trust (R247/0512), UK. The collection of the 
hair samples was also funded by the Dunhill Medical Trust (R247/0512). MKi is supported by the 
Medical Research Council (K013351), Academy of Finland and an ESRC professorship. MJS is 
partly supported by the British Heart Foundation. MKu is partly supported by the Economic and 
Social Research Council (RES-596-28-0001). 
 
ACKNOWLEDGEMENTS 
This work was performed at Department of Epidemiology and Public Health, University College 
London Medical School. The Whitehall II study has been supported by grants from the Medical 
Research Council (K013351); British Heart Foundation; National Heart Lung and Blood Institute 
(R01HL36310), US, NIH: National Institute on Aging (R01AG13196 and R01AG34454), US, NIH; 
Agency for Health Care Policy Research (HS06516); and the Dunhill Medical Trust (R247/0512), 
UK. We thank all participating men and women in the Whitehall II Study, as well as all Whitehall II 
research scientists, study and data managers and clinical and administrative staff who make the study 
possible. MKi is supported by the Medical Research Council (K013351), Academy of Finland and an 
  Abell et al.,  
18 
 
ESRC professorship. MJS is partly supported by the British Heart Foundation. MKu is partly 
supported by the Economic and Social Research Council (RES-596-28-0001). 
 
REFERENCES  
 
Boesch, M., Sefidan, S., Annen, H., Ehlert, U., Roos, L., Van Uum, S., . . . La Marca, R., 2015. Hair 
cortisol concentration is unaffected by basic military training, but related to sociodemographic and 
environmental factors. Stress-the International Journal on the Biology of Stress 18, 35-41. 
Braig, S., Grabher, F., Ntomchukwu, C., Reister, F., Stalder, T., Kirschbaum, C., . . . Rothenbacher, 
D., 2015. Determinants of maternal hair cortisol concentrations at delivery reflecting the last trimester 
of pregnancy. Psychoneuroendocrinology 52, 289-296. 
Broderick, J.E., Arnold, D., Kudielka, B.M., Kirschbaum, C., 2004. Salivary cortisol sampling 
compliance: comparison of patients and healthy volunteers. Psychoneuroendocrinology 29, 636-650. 
Brunner, E.J., Hemingway, H., Walker, B.R., Page, M., Clarke, P., Juneja, M., . . . Marmot, M.G., 
2002. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-
control study. Circulation 106, 2659-2665. 
Chen, Z., Li, J., Zhang, J., Xing, X., Gao, W., Lu, Z., Deng, H., 2013. Simultaneous determination of 
hair cortisol, cortisone and DHEAS with liquid chromatography-electrospray ionization-tandem mass 
spectrometry in negative mode. Journal of Chromatography B-Analytical Technologies in the 
Biomedical and Life Sciences 929, 187-194. 
Dettenborn, L., Muhtz, C., Skoluda, N., Stalder, T., Steudte, S., Hinkelmann, K., . . . Otte, C., 2012a. 
Introducing a novel method to assess cumulative steroid concentrations: Increased hair cortisol 
concentrations over 6 months in medicated patients with depression. Stress-the International Journal 
on the Biology of Stress 15, 348-353. 
Dettenborn, L., Tietze, A., Kirschbaum, C., Stalder, T., 2012b. The assessment of cortisol in human 
hair: Associations with sociodemographic variables and potential confounders. Stress-the 
International Journal on the Biology of Stress 15, 578-588. 
Feller, S., Vigl, M., Bergmann, M.M., Boeing, H., Kirschbaum, C., Stalder, T., 2014. Predictors of 
hair cortisol concentrations in older adults. Psychoneuroendocrinology 39, 132-140. 
Gao, W., Stalder, T., Foley, P., Rauh, M., Deng, H., Kirschbaum, C., 2013. Quantitative analysis of 
steroid hormones in human hair using a column-switching LC-APCI-MS/MS assay. Journal of 
Chromatography B-Analytical Technologies in the Biomedical and Life Sciences 928, 1-8. 
Gao, W., Xie, Q., Jin, J., Qiao, T., Wang, H., Chen, L., . . . Lu, Z., 2010. HPLC-FLU detection of 
cortisol distribution in human hair. Clin. Biochem. 43, 677-682. 
  Abell et al.,  
19 
 
Groeneveld, M.G., Vermeer, H.J., Linting, M., Noppe, G., van Rossum, E.F.C., van Ijzendoorn, M.H., 
2013. Children's hair cortisol as a biomarker of stress at school entry. Stress-the International Journal 
on the Biology of Stress 16, 711-715. 
Hellhammer, J., Fries, E., Schweisthal, O.W., Schlotz, W., Stone, A.A., Hagemann, D., 2007. Several 
daily measurements are necessary to reliably assess the cortisol rise after awakening: state- and trait 
components. Psychoneuroendocrinology 32, 80-86. 
Henley, P., Jahedmotlagh, Z., Thomson, S., Hill, J., Darnell, R., Jacobs, D., . . . Koren, G., 2013. Hair 
Cortisol as a Biomarker of Stress Among a First Nation in Canada. Ther. Drug Monit. 35, 595-599. 
Kirschbaum, C., Tietze, A., Skoluda, N., Dettenborn, L., 2009. Hair as a retrospective calendar of 
cortisol production-Increased cortisol incorporation into hair in the third trimester of pregnancy. 
Psychoneuroendocrinology 34, 32-37. 
Li, J., Xie, Q., Gao, W., Xu, Y., Wang, S., Deng, H., Lu, Z., 2012. Time course of cortisol loss in hair 
segments under immersion in hot water. Clin. Chim. Acta 413, 434-440. 
Lightman, S.L., Wiles, C.C., Atkinson, H.C., Henley, D.E., Russell, G.M., Leendertz, J.A., . . . 
Conway-Campbell, B.L., 2008. The significance of glucocorticoid pulsatility. Eur. J. Pharmacol. 583, 
255-262. 
Manenschijn, L., Koper, J.W., Lamberts, S.W., van Rossum, E.F., 2011. Evaluation of a method to 
measure long term cortisol levels. Steroids 76, 1032-1036. 
Manenschijn, L., Koper, J.W., van den Akker, E.L.T., de Heide, L.J.M., Geerdink, E.A.M., de Jong, 
F.H., . . . van Rossum, E.F.C., 2012. A Novel Tool in the Diagnosis and Follow-Up of (Cyclic) 
Cushing's Syndrome: Measurement of Long-Term Cortisol in Scalp Hair. J. Clin. Endocrinol. Metab. 
97, E1836-E1843. 
Manenschijn, L., Schaap, L., van Schoor, N.M., van der Pas, S., Peeters, G.M.E.E., Lips, P., . . . van 
Rossum, E.F.C., 2013. High long-term cortisol levels, measured in scalp hair, are associated with a 
history of cardiovascular disease. The Journal of clinical endocrinology and metabolism 98, 2078-
2083. 
Marmot, M., Brunner, E., 2005. Cohort profile: the Whitehall II study. Int. J. Epidemiol. 34, 251-256. 
Meyer, J.S., Novak, M.A., 2012. Minireview: Hair Cortisol: A Novel Biomarker of Hypothalamic-
Pituitary-Adrenocortical Activity. Endocrinology 153, 4120-4127. 
O'Brien, K.M., Tronick, E.Z., Moore, C.L., 2013. Relationship between Hair Cortisol and Perceived 
Chronic Stress in a Diverse Sample. Stress Health 29, 337-344. 
  Abell et al.,  
20 
 
Pereg, D., Gow, R., Mosseri, M., Lishner, M., Rieder, M., Van Uum, S., Koren, G., 2011. Hair 
cortisol and the risk for acute myocardial infarction in adult men. Stress-the International Journal on 
the Biology of Stress 14, 73-81. 
Pou, K.M., Massaro, J.M., Hoffmann, U., Vasan, R.S., Maurovich-Horvat, P., Larson, M.G., . . . Fox, 
C.S., 2007. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers 
of inflammation and oxidative stress: the Framingham Heart Study. Circulation 116, 1234-1241. 
Radloff, L.S., 1977. The CES-D Scale: A Self-Report Depression Scale for Research in the General 
Population. Appl. Psychol. Meas. 1, 385-401. 
Raul, J.S., Cirimele, V., Ludes, B., Kintz, P., 2004. Detection of physiological concentrations of 
cortisol and cortisone in human hair. Clin. Biochem. 37, 1105-1111. 
Remer, T., Maser-Gluth, C., Wudy, S.A., 2008. Glucocorticoid measurements in health and disease--
metabolic implications and the potential of 24-h urine analyses. Mini Rev. Med. Chem. 8, 153-170. 
Rippe, R.C., Noppe, G., Windhorst, D.A., Tiemeier, H., van Rossum, E.F., Jaddoe, V.W., . . . van den 
Akker, E.L., 2016. Splitting hair for cortisol? Associations of socio-economic status, ethnicity, hair 
color, gender and other child characteristics with hair cortisol and cortisone. 
Psychoneuroendocrinology 66, 56-64. 
Russell, E., Russell, G., Koren, M., Rieder, S., Van, U., 2012. Hair cortisol as a biological marker of 
chronic stress: Current status, future directions and unanswered questions. Psychoneuroendocrinology 
37, 589-601. 
Sauve, B., Koren, G., Walsh, G., Tokmakejian, S., Van Uum, S.H., 2007. Measurement of cortisol in 
human hair as a biomarker of systemic exposure. Clin. Invest. Med. 30, E183-191. 
Serwinski, B., Salavecz, G., Kirschbaum, C., Steptoe, A., 2016. Associations between hair cortisol 
concentration, income, income dynamics and status incongruity in healthy middle-aged women. 
Psychoneuroendocrinology 67, 182-188. 
Sharpley, C.F., McFarlane, J.R., Slominski, A., 2012. Stress-linked cortisol concentrations in hair: 
what we know and what we need to know. Rev. Neurosci. 23, 111-121. 
Stalder, T., Kirschbaum, C., 2012. Analysis of cortisol in hair - State of the art and future directions. 
Brain Behavior and Immunity 26, 1019-1029. 
Stalder, T., Kirschbaum, C., Alexander, N., Bornstein, S.R., Gao, W., Miller, R., . . . Fischer, J.E., 
2013. Cortisol in Hair and the Metabolic Syndrome. J. Clin. Endocrinol. Metab. 98, 2573-2580. 
  Abell et al.,  
21 
 
Stalder, T., Kirschbaum, C., Heinze, K., Steudte, S., Foley, P., Tietze, A., Dettenborn, L., 2010. Use 
of hair cortisol analysis to detect hypercortisolism during active drinking phases in alcohol-dependent 
individuals. Biol. Psychol. 85, 357-360. 
Stalder, T., Steudte, S., Alexander, N., Miller, R., Gao, W., Dettenborn, L., Kirschbaum, C., 2012a. 
Cortisol in hair, body mass index and stress-related measures. Biol. Psychol. 90, 218-223. 
Stalder, T., Steudte, S., Miller, R., Skoluda, N., Dettenborn, L., Kirschbaum, C., 2012b. 
Intraindividual stability of hair cortisol concentrations. Psychoneuroendocrinology 37, 602-610. 
Stalder, T., Tietze, A., Steudte, S., Alexander, N., Dettenborn, L., Kirschbaum, C., 2014. Elevated 
hair cortisol levels in chronically stressed dementia caregivers. Psychoneuroendocrinology 47, 26-30. 
Staufenbiel, S.M., Penninx, B.W.J.H., de Rijke, Y.B., van den Akker, E.L.T., van Rossum, E.F.C., 
2015. Determinants of hair cortisol and hair cortisone concentrations in adults. 
Psychoneuroendocrinology 60, 182-194. 
Staufenbiel, S.M., Penninx, B.W.J.H., Spijker, A.T., Elzinga, B.M., van Rossum, E.F.C., 2013. Hair 
cortisol, stress exposure, and mental health in humans: A systematic review. 
Psychoneuroendocrinology 38, 1220-1235. 
Swerdlow, D.I., Preiss, D., Kuchenbaecker, K.B., Holmes, M.V., Engmann, J.E., Shah, T., . . . Sattar, 
N., 2015. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from 
genetic analysis and randomised trials. Lancet 385, 351-361. 
Thomson, S., Koren, G., Fraser, L.A., Rieder, M., Friedman, T.C., Van Uum, S.H.M., 2010. Hair 
Analysis Provides a Historical Record of Cortisol Levels in Cushing's Syndrome. Experimental and 
Clinical Endocrinology & Diabetes 118, 133-138. 
Veldhorst, M.A., Noppe, G., Jongejan, M.H., Kok, C.B., Mekic, S., Koper, J.W., . . . van den Akker, 
E.L., 2014. Increased scalp hair cortisol concentrations in obese children. J. Clin. Endocrinol. Metab. 
99, 285-290. 
Walker, B.R., Andrew, R., 2006. Tissue Production of Cortisol by 11β-Hydroxysteroid 
Dehydrogenase Type 1 and Metabolic Disease. Ann. N. Y. Acad. Sci. 1083, 165-184. 
Wennig, R., 2000. Potential problems with the interpretation of hair analysis results. Forensic Sci. Int. 
107, 5-12. 
WHO, 2006. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of 
a WHO/IDF consultation. World Health Organization. 
WHO, 2011. Abbreviated Report of a WHO Consultation Use of Glycated Haemoglobin (HbA1c) in 
the Diagnosis of Diabetes Mellitus. World Health Organization  
  Abell et al.,  
22 
 
Wosu, A.C., Gelaye, B., Valdimarsdóttir, U., Kirschbaum, C., Stalder, T., Shields, A.E., Williams, 
M.A., 2015. Hair cortisol in relation to sociodemographic and lifestyle characteristics in a multiethnic 
US sample. Ann. Epidemiol. 25, 90-95.e92. 
Wosu, A.C., Valdimarsdottir, U., Shields, A.E., Williams, D.R., Williams, M.A., 2013. Correlates of 
cortisol in human hair: implications for epidemiologic studies on health effects of chronic stress. Ann. 
Epidemiol. 23, 797-811. 
Young, E.A., Abelson, J., Lightman, S.L., 2004. Cortisol pulsatility and its role in stress regulation 
and health. Front. Neuroendocrinol. 25, 69-76. 
 
 
 
Figure 1: Geometric mean (± 95% CI) Hair Cortisol Concentrations in participants by CES-D 
depressive symptoms scale a 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a P value  from t-test = 0.01 
 
 
 
 
 
Table 1: Characteristics of study participants (N= 3675) 
Characteristic N % Median HCC 
Sex: 
    Male 
    Female  
 
2513 
1162 
 
68.4 
31.6 
 
3.1 
2.4 
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Age groups: 
   59-64 
   65-74 
   75-85 
  
932 
1899 
844 
 
25.4 
51.7 
23.0 
 
2.9 
2.8 
2.8 
Ethnicity: 
   White 
   South Asian 
   Black 
   Other  
 
3460 
151 
36 
28  
 
94.2 
4.1 
1.0 
0.8 
 
2.9 
2.5 
5.3 
4.0 
Grade: 
    Administrative 
   Prof/exec 
   Clerical/support  
 
1811 
1529 
335 
 
49.3 
41.6 
9.1 
 
3.0 
2.8 
2.4 
Original hair colour: 
   Grey/white 
   Blonde 
Red 
   Brown 
Black 
 
2876 
96 
32 
473 
198 
 
78.3 
2.6 
0.9 
12.9 
5.4 
 
2.9 
2.4 
2.9 
2.8 
3.1 
Hair dyed:      
   Yes 
   No 
 
608 
3067 
 
16.5 
83.5 
 
2.3 
3.0 
Hair Treated:  
   Yes 
    No 
 
149 
3526 
 
4.1 
96.0 
 
2.6 
2.9 
Hair washing freq.: 
   ≤ Once a week  
   2-4 times per week  
   > 4  times per week 
 
1119 
1716 
  840 
 
30.5 
46.7 
22.9 
 
2.9 
2.8 
2.9 
Season collected: 
Winter 
Winter-spring 
Spring 
Spring-summer 
Summer 
Summer-autumn 
Autumn 
Autumn-winter 
 
454 
561 
320 
690 
337 
507 
332 
474 
 
12.4 
15.3 
8.7 
18.8 
9.2 
13.8 
9.0 
12.9 
 
3.5 
2.6 
2.2 
2.6 
2.8 
2.9 
3.1 
3.2 
Storage (months): 
   18 months or less 
   19-24 months 
   > 24 months 
 
570 
1557 
1548 
 
15.5 
42.4 
42.1 
 
3.1 
3.2 
2.5 
Steroids medication:  
   No 
   Yes (local) 
   Yes (systemic) 
 
3341 
264 
70 
 
90.9 
7.2 
1.9 
 
2.9 
2.9 
1.6 
CVD drugs:   
   Yes 
   No 
 
2174 
1501 
 
59.2 
40.8 
 
2.9 
2.8 
Diabetes:      
   No 
   Yes 
 
3166 
527 
 
85.7 
14.3 
 
2.8 
3.2 
CHD:             
    No 
   Yes 
 
2664 
1011 
 
72.5 
27.5 
 
2.8 
3.1 
Stroke:         
    No 
Yes 
 
3552 
123 
 
96.7 
3.4 
 
2.9 
3.2 
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CES-D:          
   No  
   Yes 
 
3239 
436 
 
88.1 
11.9 
 
2.8 
3.1 
BMI: 
Underweight (<18.5) 
Healthy weight (18.5-24.9) 
Overweight (25-29.9) 
Obese (>30) 
 
46 
1,368 
1,532 
729 
 
1.25 
37.2 
41.7 
19.8 
 
2.4 
2.6 
3.0 
3.3 
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Table 2: Comparison of those included and excluded from the study sample1  
 In study sample 
(N=  3,675) 
Not in study 
sample 
(N= 2,633 ) 
P value 
 Mean (SD) or 
% 
 
Mean (SD) or % 
 
 
Sex (% men) 68.4 74.0 <0.001 
Age (yr) 69.8 (5.8) 69.9 (6.0) 0.301 
Ethnicity (% white) 94.2 90.5 <0.001 
Employment grade (% 
lowest) 
9.1 10.7 0.045 
HCC 2 3.5 (3.7) 6.3 (12.7) <0.001 
Original hair colour 
(%grey/white) 
78.3 79.8 0.100 
Hair dyed (% dyed) 16.5 20.8 0.004 
Hair treated (% treated) 4.1 4.7 0.408 
Hair washing freq.(once a 
week) 
30.5 31.5 0.367 
Season collected (% spring) 8.7 8.5 <0.001 
Storage (% ≤ 18 months) 15.5   17.8  0.002 
Steroid medication (% No) 90.9 91.4 0.544 
CVD drugs 40.8 37.7 0.011 
BMI % obese 19.8 19.0 0.179 
Diabetes 85.7 83.8 0.035 
CHD 72.5 74.0 0.187 
Stroke 96.7 96.1 0.266 
CES-D 88.1 85.9 0.011 
1Among those eligible participants at phase 11 (N=6,308); 2 Geo-means of HCC 
 
 
 
 
Table 3: Hair cortisol concentration by demographic and hair characteristics  
Characteristic Unadjusted  Mutually adjusteda 
Meanb % differencec (95%CI) P 
value 
 % difference 
(95%CI) 
P value 
Sex:       
    Male 3.80 Ref   Ref  
    Female 2.90 -23.6 (-28.9, -17.8) <0.001  -17.0 (-24.8, -8.4) <0.001 
Age groups:       
   59-64 3.40 Ref   Ref  
   65-74 3.55 4.4 (-3.9, 13.3.) 0.308  2.7 (-5.5, 11.6) 0.534 
   75-85 3.44 1.0 (-8.4, 11.4) 0.842  -2.2 (-11.9, 8.5) 0.670 
Ethnicity:       
   White 3.48 Ref   Ref  
  South Asian 3.21 -7.9 (-22.4,9.3) 0.344  -4.3 (-20.1,14.6) 0.632 
  Black 4.44 27.3 (-9.9,79.7) 0.171  39.6 (2.1,99.0) 0.065 
   Other 4.24 21.6 (-17.7, 79.7) 0.326  32.7 (-10.2,96.0) 0.156 
Last known grade:       
   Administrative 3.67 Ref   Ref  
   Prof/exec 3.34 -9.0 (-15.3,-2.2) 0.010  -3.9 (-10.7,3.5) 0.294 
   Clerical/support 3.19 -13.1 (-23.1,-1.8) 0.025  1.1 (-11.6,15.6) 0.871 
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Original hair 
colour:  
      
   Grey/White 3.48 Ref   Ref  
   Blonde 3.01 -13.3 (-30.0,7.3) 0.189  -0.7 (-19.9, 23.1) 0.950 
Red 3.45 -0.7 (-31.2, 43.1) 0.968  6.5 (-26.0, 53.2) 0.735 
   Brown 3.36 -3.3 (-12.7,7.0) 0.514  4.3 (-6.1, 15.8) 0.434 
Black 4.24 22.0 (4.9, 41.9) 0.010  23.7 (5.8, 44.7) 0.008 
Hair dyed:       
   No 3.65 Ref   Ref  
   Yes 2.76 -24.3 (-30.9,-17.1) <0.001  -12.5 (-22.0,-1.9) 0.022 
Hair treated:       
   No 3.51 Ref   Ref  
   Yes 2.99 -14.8 (-28.3,1.2) 0.068  -0.6 (-17.0,19.0) 0.945 
Hair washing:       
   ≤ Once a week  3.58 Ref   Ref  
   2-4 times per week 3.42 -4.4 (-11.6,3.5) 0.269  -3.8 (-11.3, 4.3) 0.343 
   ≥ 5 times per week 3.50 -2.3 (-11.1,7.3) 0.630  -8.4 (-17.0, 1.1) 0.081 
Season collected: d       
Winter 4.21 Ref   Ref  
Winter-spring 3.26 -22.7 (-32.1, -12.1) <0.001  -29.9 (-40.8, -17.0) <0.001 
Spring 2.78 -34.0(-43.2,-23.3) <0.001  -36.0 (-46.7,-23.0) <0.001 
Spring-summer 3.25 -23.0 (-32.0, -12.9) <0.001  -25.4 (-36.7, -12.2) <0.001 
Summer 3.42 -18.8 (-29.9,-5.9) 0.006  -20.7 (-33.9, -4.8) 0.013 
Summer-autumn 3.49 17.1 (-27.4, -5.4) 0.005  -12.9 (-24.4, 0.3) 0.056 
Autumn 3.83 -9.2 (-21.7,5.3) 0.200  -6.4 (-20.2, 9.8) 0.420 
Autumn-winter 3.86 -8.4 (-20.0, 4.8) 0.199  -7.4 (-20.1, 7.3) 0.306 
Storage:       
   ≤ 18 months 3.73 Ref   Ref  
  19-24 months 3.77 1.1 (-8.5,11.8) 0.825  -23.6 (-36.5, -8.1) 0.004 
   > 24 months 3.14 -15.8 (-23.9,-6.9) 0.001  -18.0 (-26.1, -9.0) <0.001 
a Adjusted for sex, age, ethnicity, grade, hair colour, hair dye, hair treatment, hair washing, season, storage 
b Unadjusted geometric means 
c Percentage difference in hair cortisol concentration from the reference group 
d An eight category variable was created to take account of hair growth which during the three month sample overlapped two 
seasons 
 
Table 4: Hair cortisol concentration by medication and health status 
Characteristic Unadjusted  Fully adjusteda 
Meanb % differencec 
(95%CI) 
P 
value 
 % difference 
(95%CI) 
P 
value 
       
Medications       
       
Steriods:       
    No 3.50 Ref   Ref  
    Yes (local) 3.72 6.2 (-6.8, 21.2) 0.367  5.8 (-7.1,20.5) 0.393 
 
    Yes (systemic) 2.17 -37.9 (-51.6, -20.4)  <0.001  -37.5 (-51.0,-20.2) <0.001 
 
CVD drugs:       
   No 3.25 Ref   Ref  
   Yes 3.66 12.5 (5.0, 20.6) 0.001  2.7 (-4.6, 10.5) 0.477 
       
Health status       
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BMI:       
Underweight 3.1 2.5 (-24.6, 39.4) 0.873  7.7 (-20.6,46.0)  0.634 
Healthy weight 3.1 Ref   Ref  
Overweight 3.7 20.2 (11.4, 29.7) <0.001  17.7 (9.0, 27.0) <0.001 
Obese 4.0 31.5 (19.7, 44.4) <0.001 
 
33.0 (20.7, 46.5) <0.001 
Diabetes:       
   No 3.4 Ref   Ref  
   Yes 4.1 21.1 (9.9, 33.4) <0.001  14.7 (3.8, 26.8) 0.007 
 
Coronary heart 
disease: 
      
   No 3.4 Ref   Ref  
   Yes 3.6 6.8 (-1.0,15.2) 0.090  1.4 (-6.2, 9.5) 0.735 
 
Stroke:        
   No 3.5 Ref   Ref  
   Yes 3.9 12.5 (-6.9, 35.9) 0.222  6.0 (-12.1, 28.0) 0.541 
 
Depressive 
symptoms: 
      
   No 3.44 Ref   Ref  
   Yes 3.96 15.8 (4.3, 28.6) 0.008  20.0 (8.1, 33.3) 0.001 
 
       
a Adjusted for sex, age, ethnicity, grade, hair colour, hair dye, hair treatment, hair washing, season, 
storage steroid drugs, cvd drugs, diabetes, CHD and Stroke 
b Unadjusted geometric means 
c Percentage difference in hair cortisol concentration from the reference group 
 
 
 
 
 
 
 
 
 
